MedTrace Logo

Effect of Bacillus Coagulans and Galactomannans on Obese Patients Undergoing Sleeve Gastrectomy

NCT02868489 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-09-24

No results posted yet for this study

Summary

The purpose of the study is to determine the effect of bacillus coagulans and galactomannans (LactoWise®) administration on obese patients undergoing sleeve gastrectomy by observing standard protocol measurements in patients following sleeve gastrectomy: laboratory measurements, ideal body weight, and percent estimated weight loss, in addition incorporating the Gastrointestinal Quality of Life Index (GIQLI)

Conditions

Interventions

DIETARY_SUPPLEMENT

LactoWise®

blend of bacillus coagulans and galactomannans

OTHER

Placebo

Placebo to be selected is calcium carbonate (since participant routine standard of care already includes intake of calcium citrate)

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Keith Scharf, DO FACS · Loma Linda University Health

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-07
Primary Completion
2017-11-29
Completion
2017-11-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02868489 on ClinicalTrials.gov